|
|||||
| |
2005 Germ of the Month: Newman (Streptococcus pnemoniae) Elliot (Staphylococcus epidermidis) Staphon (Staphylococcus aureus) Rocco (Enterococcus faecium), Sal (Salmonella typhimurium) and Trip (Spirochaeta treponema pallidum) Articles: Clinical Compendium: Clean Scene InvestigationsStart with Hibiclens® Clinical Compendium PDFs Hand Irritation Study - pgs. 2-3 (PDF 144k) Hibiclens vs. Alcohol Study - pgs. 4-5 (PDF 156k) Blood Neutralization Study: Hibiclens vs. Other Antiseptics - pgs. 6-7 (PDF 160k) MRSA In Vitro Testing - pgs. 8-9 (PDF 268k) CA-MRSA In Vitro Testing - pgs. 10-11 (PDF 180k) MRSA Clostridium difficile (vegetative) Time-Kill Study - pgs. 12-13 (PDF 208k) Avian Flu (H5N1) vs. Hibiclens Study - pgs. 14-15 (PDF 156k) 50 Microbes-Tentative Final Monograph (TFM) Testing - pgs. 16-17 (PDF 260k) Hand Imprint Study - pgs. 18-19 (PDF 188k) First and Last Wash of the Day Study - pgs. 20-21 (PDF 212k) Hibi Vocabulary - pgs. 22-23 (PDF 84k) Hibiclens Product Overview - pgs. 24-25 (PDF 116k) Complete Compendium (PDF 2M) 1 Protocol # 030917-150
|
|
|||
Hibiclens, the Hibiclens logo, Hibistat, the Hibistat logo, Hibigeebies, the Mölnlycke logo, and Mölnlycke are registered trademarks of Mölnlycke Group of companies. Distributed by Mölnlycke Health Care US, LLC, Norcross, Georgia 30092. ©2007 Mölnlycke Health Care AB. All rights reserved. 1.800.843.8497 www.molnlycke.com |
|||||
| |
|||||